Herceptin is a treatment for women with breast cancer whose tumors have too much HER2 protein. This type of cancer is known as "HER2-positive", "HER2+", or "HER2 overexpressing". HER2+ tumors tend to grow and spread more quickly than tumors that are not HER2+. This is why it is so important to find out your cancer's HER2 status. Back to top

Herceptin® (Trastuzumab) is a treatment for women with breast cancer whose tumors have too much HER2 protein. This type of cancer is known as "HER2-positive", "HER2+", or "HER2 overexpressing". HER2+ tumors tend to grow and spread more quickly than tumors that are not HER2+. This is why it is so important to find out your cancer's HER2 status. Clinical experience with Herceptin for the adjuvant treatment of HER2+, node-positive breast cancer began in 2000.

Herceptin is designed to target HER2+ cancer cells. Based on laboratory studies, Herceptin works 2 ways to stop the HER2+ cancer cell from growing. Herceptin also stops the HER2+ cancer cell from telling itself to grow and divide into more cancer cells

Herceptin Access Solutions™ is a reimbursement resource designed to address the informational needs of patients on Genentech products related to reimbursement. Herceptin Access Solutions provides information to doctors, on their patient's behalf, in order to help obtain timely reimbursement.

Yes, Herceptin can be given with other cancer treatments. Remember, Herceptin is not chemotherapy or hormonal therapy. The potential benefits of Herceptin are in addition to the potential benefits you may receive from surgery, chemotherapy, hormonal therapy, or radiation therapy. Herceptin is not a substitute for any of these therapies. Talk to your doctor about what therapies are right for you.

In 1998, Herceptin was approved for the treatment of HER2+ metastatic breast cancer. In 2006, the FDA approved Herceptin for the adjuvant treatment of patients with HER2+, node-positive breast cancer.

During the period you are taking both chemotherapy and Herceptin, you will have to discuss with your doctor or nurse whether you will be able to drive home after your infusion. After chemotherapy has been completed, and you are taking Herceptin alone, you will likely be able to drive home from your treatment. Everyone is different, however. It is not possible to predict whether you will feel well enough to drive after each infusion. Talk to your doctor or nurse.

Herceptin has been studied in a large clinical trial in people with HER2-positive metastatic breast cancer. People participating in the clinical trial received either chemotherapy plus Herceptin or chemotherapy alone. A clinical trial is a test of a treatment to see if it is beneficial to a particular group of people. If a treatment works well in an extensive clinical trial, it may become a new therapy that can help many people with cancer.

Herceptin has been studied in 2 large clinical trials of over 3700 women. Patients participating in the clinical trials received either Herceptin plus chemotherapy or chemotherapy alone. In addition to chemotherapy, some patients in these trials received radiation therapy, and some received hormonal therapy depending on their type of tumor.

Herceptin is recommended to be taken weekly for 52 weeks. Initially, you may receive chemotherapy for 12 weeks before starting Herceptin. Once you start Herceptin, you will also receive another chemotherapy drug (paclitaxel) for the first 12 weeks of Herceptin therapy. After completion of your therapy with paclitaxel, Herceptin is given on its own. The clinical trial results showed that Herceptin plus chemotherapy reduced the risk of cancer returning by 52% compared to chemotherapy alone.

One study is looking at the drug in a variety of solid tumors and another is assessing it in either ovarian cancer or cancer of the peritoneum (the cells lining the abdomen). Both studies are being carried out through NCI-sponsored cooperative clinical trial groups, which are networks of research centers that conduct joint studies and pool their data. Solid tumors: This is a phase I/pilot study of low-dose interleukin-2 plus Herceptin in solid tumors - i.e.

On Sept. 2, 1998, an FDA advisory committee recommended approval of the drug for marketing. The FDA is now working with Genentech to determine the labeling of the drug and the conduct of continued studies before making a decision about approval. NOTE: Herceptin was approved by the FDA on September 25, 1998 (see Biotechnology Breakthrough In Breast Cancer Wins FDA Approval).

You must be willing to work on your computer at least a few hours per week, and you must be able to follow simple directions. As long as you are not a complete moron, and you will actually DO THE WORK, my book will be able to help you make money. Will you make me a website that will make $1 million dollars? If you do, I will tell everyone you are the real deal. Let me think...hmmm...NO. Use my book yourself and make your own $1 million dollars.

EVERYONE! Classes are for anyone interested in performance enhancement. anyone who has injuries from exercise or from lack of it. Or, for anyone interested in learning new ways to care for their mind-body as well as for those burned out by ther rigors or traditional exercise. This program is great for cross-training or can be done exclusively to keep you fit and strong.

YES. ADD symptoms do not necessarily go away as a person gets older. Adults can also benefit from neurofeedback training to the same extent as children. They can achieve long term improvement in attention span, impulse control, reading, listening skills, and time management. In addition, many adults also want assistance with stress and tension. For decreasing tension, neurofeedback of the brain waves can be combined with biofeedback.

Individuals of all ages could benefit from physiotherapy services. The physiotherapy scope of practice is extremely diverse in treating functional disorders. Some areas addressed within the physiotherapy scope of practice includes: Ligament Sprains, Muscle Strains and Contusions (bruises) immediately following injury or at any stage of healing.

Patients with history of ischemic stroke or TIA who are not already known to have AF may be tested to help decide which patients are at highest risk for undiagnosed AF and who may benefit the most from more extensive ambulatory cardiac monitoring.The test can only be ordered by a physician and is not for screening the general population. Back to top of page

One well-designed research study found that adding memantine to donepezil was beneficial. It is also standard practice for many doctors to combine cholinesterase inhibitors and vitamin E, although more recently vitamin E has fallen out of favor as a treatment.

Yes, it means less sick leave and early return to work e.g. after a gall bladder operation, an employee finds it difficult to resume work till about 6 weeks to 3 months. Here, they can be back to work in a week.

OutOfPocket.com benefits the insured, uninsured, and under-insured. Knowledge is powerful. Consumers can look up how much a routine health care service will cost before they visit a doctors office or facility. Not the inflated list price, but the true price for the service. The 10 million consumers with high-deductible health insurance plans need to know what a specific procedure or service will cost up front in order to find the best value and make the most out of health care dollars.

This program is especially effective for anyone whose ability to work productively is limited by pain caused by nerve entrapment and/or tendinitis caused by inflammation. Successful MouseKeyDo users have experienced relief from many specific diagnoses, including lateral and medial epicondylitis, DeQuervain's tenosynovitis, ganglionic cysts, carpal tunnel syndrome, cubital tunnel syndrome, radial nerve entrapment, thoracic outlet syndrome, and myofascial neck and shoulder pain syndrome.

Coverage for care in hospitals and skilled nursing facilities is measured in "benefit periods." In each benefit period, there are limits to the number of days Medicare will help pay for inpatient hospital, skilled nursing facility or hospice care. Once the limit is exceeded, the beneficiary is responsible for all charges for each additional day of care. A benefit period begins the day of admission to a hospital.

Simply put, Acedge is a small 1/2 inch device which attaches to the end of your racquet in such a way as to improve leverage [which affects racquet head speed] during the service upward swing towards the ball. With Acedge, an active player will soon acquire that service power that the pros call "heat.

Laparoscopic management provide less postoperative morbidity. Laparoscopic management is a useful method for reducing hospital stay, complications and return to normal activity. The main advantages are:

We recommend that you take all our products with food. This way you will be taking advantage of the digestive processes that are already occurring. Plus, fulvic enhances the absorption and utilization of all nutrients it comes in contact with, so you will be making better use of the nutrients in your food. We also recommend that you split your dosage up, if possible, and take 1/2 a dose in the morning and the other 1/2 in the early evening, with dinner.

Both men and women seek electrolysis not only as a solution to the problem of unwanted hair growth, but as a convenience that frees them from the daily effort of maintaining a hair free look on the face and body. For many, electrolysis becomes a necessity, especially for those who were discouraged with the unsuccessful results of temporary hair removal methods such as laser, waxing, tweezing, shaving, bleaching, and depilatories.